Compier eTMF

Home / Innovation / Compier eTMF

Collaborate and Digitally Streamline Trial Master File Documentation Across Studies and Sites using Compier eTMF

With increasing concerns on patient safety, Regulatory agencies expect sponsors to have clinical sites audit-ready with an accurate Trial Master File (TMF) to account for all trial activities and provide complete visibility on the trial conduct progress with complete documentation. Regulators such as the European Medicines Agency and Medicines & Healthcare Products Regulatory Agency (MHRA) expect, at a minimum, that an organization’s TMF accurately reconstructs how a clinical trial was conducted to demonstrate effective sponsor oversight, support decisions made, and comply with GCP guidelines.

Introducing Compier eTMF

Compier eTMF is a highly configurable GxP compliant digital Trial Master File (TMF) management solution that allows sponsors to develop, track, share, and manage all types of clinical trial documentation as per the TMF Reference Model for Trial Master Files, the EDM Reference Model for Regulatory Documents and the ICH eCTD model for Regulatory Submissions.

With the goal of establishing lean and insights driven Trial Master File (TMF) management across clinical sites, the Compier platform has modern technology capabilities to enable sponsors take informed decisions and always stay audit ready for regulatory inspections.


Key Solution Capabilities

  • Compier eTMF offers a secure and centralized digital collaboration space
  • The platform has robust search and document retrieval and content viewing capabilities
  • Allows users to quickly find and access documents based on user role permissions
  • Facilitates the management of a wide-variety of clinical trial documents in varying size and formats.
  • Allows sponsors to setup flexible metadata configurations to optimize Trial Documentation Management
  • Provides stakeholders a comprehensive oversight on the progress of milestones and related TMF documentation
  • Has powerful features to facilitate electronic records import and export
  • Facilitates fast and accurate data exchange between other source document systems like EDC, CTMS, etc.
  • Compier eTMF maintains the confidentiality and integrity of the data along with authorized access controls, single sign on (SSO) and active directory integrated thus making it regulatory 21 CFR Part 11 compliant cloud platform.
  • The documents and data are handled with multiple protection privacy in the areas of patient safety, data protection and security.
  • Has time-based and event-based built-in alerts and notifications
  • Allows tracking milestone progress and ensuring that all relevant clinical trial documents are complete and maintained in a compliant manner.
  • Leverage standard reports to gain insights on documentation progress, open issues and overall quality
  • Keeps users informed on critical timelines, document status, key risks and activities summary

Stay Audit Ready with Compier eTMF

Business Plan

How We Deliver

Compier eTMF is offered as a fully-managed SaaS solution to pharma companies, CROs and other life sciences organizations. Clients can leverage our pre-validated platform to rapidly begin the eTMF setup. Our team of specialized consultants will provide extended knowledge support for the eTMF implementation and rollout.

Recent News / Articles

4 Effective Strategies to Accelerate Site Selection to Activation

Introduction to the site selection process Clinical research organizations (CRO) predominantly rely on the internal networks and investigator database to support a clinical study for a drug. As the clinical sphere continues to expand at a rapid pace, there is an upsurge in demand for clinical trial sites worldwide. CROs are striving for new sites […]

Aggregate Reporting – Significance, Classification and Challenges

Aggregate reports are the cumulative reports in the database that emphasise on evaluation of safety profile and risk-benefit analysis of a drug. Aggregate reporting is the process of compilation and submission of aggregate reports to the regulatory agencies over the period of the product’s life cycle (during pre-marketing and post-marketing phase) to provide a comprehensive [...]

Literature Screening – Process overview, challenges en-route and the scope for automation

Medical and scientific literature is a valuable source of safety information that helps in monitoring benefit-risk profiles and emerging safety issues of medicinal products. Literature screening is conducted to ascertain abstracts and articles that provide crucial information on serious and non-serious Individual Case Safety Reports (ICSR) reports and risk-benefit assessment of a drug. The scientific […]

To Know More Please Get in Touch With Us